ICMI 2015

T.97 TIMP1 deficiency aggravates the TNBS-colitis course in mice and promotes post-surgical recurrence in Crohn's disease

Thursday, July 16, 2015
Grand Hall and Gallery, Ground Floor & 1st Floor (Maritim Hotel)
Arce Garcia-Jaraquemada, Sr , Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
Anna Garcia-Hidalgo, BSc , Germans Trias i Pujol Health Sciences Research Institute, Badalona, Spain
Violeta Loren, PhD , Health Sciences Research Institute of the “Germans Trias i Pujol” Foundation (IGTP), Badalona, Barcelona, Spain
Yamile Zabana, MD , Germans Trias i Pujol Health Research Institute (IGTP), Badalona, Spain
Farah Kamberovic, BSc , Germans Trias i Pujol Health Sciences Research Institute, Badalona, Spain
Eduard Cabr, MD , Germans Trias i Pujol University Hospital, Badalona, Spain
Eugeni Domenech, MD-PhD , CIBER, Madrid, Spain
Elisabet Pedrosa, PhD , Germans Trias i Pujol Health Research Institute (IGTP), Badalona, Spain
Isabel Ojanguren, MD , Germans Trias i Pujol University Hospital, Badalona, Spain
Josep Manye, PhD , CIBER, Madrid, Spain
Introduction: The extracellular matrix (ECM) activity plays a key role in intestinal wound healing.  Crohn’s disease (CD) could disturb the intestinal balance between metalloproteinases (MMPs) and tissue inhibitor of MMPs (TIMP).

Objective: 1) Study whether imbalances in ECM are related with early post-surgical recurrence (PSR) in the CD, and 2) its effect on TNBS-colitis.  

Methods:. ECM activity were measured by transcriptome analysis (RT-PCR validated) and protein microarrays from 20 CD ileo-cecal resections (5 of them with PSR<18 months post-surgery) and 10 controls. Paraffin embedded samples were stained with Masson’sTrichrome. Apart from that, TNBS-colitis course was assessed in wild-type and TIMP1-deficent mice by “in vivo” bioluminiscence imaging and tomography.

Results

The transcriptome reflected a high activity of ECM in CD, while protein analysis showed increased levels of all TIMPs in ileo-cecal resections compared to control. In addition, TIMP1 levels significantly correlated with MMP1 [R2=0.59] and MMP13 [R2=0.58]. In contrast to non-early PSR, early PSR patients showed reduced levels of TIMP1 [4.2 (3.1-6.4) vs. 3.1 (2.0-8.1); mg/ml], TGFβ1 [7.7 (4.7-8.5) vs. 4.5 (1.7-5.5); 103 RU], and fibrosis [8 (5-10) vs. 4 (2-6)] Furthermore, TIMP1-deficient mice with TNBS-colitis showed higher bioluminiscence emission than wild-type mice (e.g. 6 days post-colitis: 6,93x104 vs. 0,4x104; fot·sr-1·cm-2; p<0.05), and a greater transmural thickness (2.8 vs. 0.9 mm2) and stenosis [4 (2-5) vs. 0 (0-2)].

Conclusions

CD patients with early PSR show lower basal levels of intestinal TIMP1 and TGFβ1 than patients without early PSR. TIMP1 deficiency leads to more aggressive TNBS-colitis course.